Galera Therapeutics, Inc. (GRTX)
USD 0.02
(8.11%)
USD 0.02
(8.11%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -59.08 Million USD | 5.05% |
| 2022 | -62.22 Million USD | 29.07% |
| 2021 | -87.72 Million USD | -18.2% |
| 2020 | -74.21 Million USD | -42.92% |
| 2019 | -51.93 Million USD | -119.34% |
| 2018 | -23.67 Million USD | -0.56% |
| 2017 | -23.54 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -4.06 Million USD | 7.24% |
| 2024 Q1 | -4.38 Million USD | 21.59% |
| 2023 Q3 | -15.07 Million USD | 27.23% |
| 2023 FY | -59.08 Million USD | 5.05% |
| 2023 Q4 | -5.58 Million USD | 62.93% |
| 2023 Q2 | -20.71 Million USD | 19.6% |
| 2023 Q1 | -25.76 Million USD | -59.14% |
| 2022 Q4 | -16.18 Million USD | 15.28% |
| 2022 Q2 | -17.16 Million USD | 3.22% |
| 2022 Q1 | -17.73 Million USD | -5.5% |
| 2022 FY | -62.22 Million USD | 29.07% |
| 2022 Q3 | -19.1 Million USD | -11.34% |
| 2021 Q2 | -22.38 Million USD | -19.62% |
| 2021 FY | -87.72 Million USD | -18.2% |
| 2021 Q3 | -22.62 Million USD | -1.07% |
| 2021 Q4 | -16.8 Million USD | 25.72% |
| 2021 Q1 | -18.71 Million USD | 6.73% |
| 2020 Q4 | -20.06 Million USD | -17.49% |
| 2020 FY | -74.21 Million USD | -42.92% |
| 2020 Q3 | -17.07 Million USD | 8.46% |
| 2020 Q2 | -18.65 Million USD | -1.3% |
| 2020 Q1 | -18.41 Million USD | -10.47% |
| 2019 Q1 | -10.34 Million USD | -20.86% |
| 2019 FY | -51.93 Million USD | -119.34% |
| 2019 Q4 | -16.67 Million USD | -24.87% |
| 2019 Q3 | -13.35 Million USD | -15.51% |
| 2019 Q2 | -11.55 Million USD | -11.68% |
| 2018 Q2 | -6.13 Million USD | 0.0% |
| 2018 Q1 | -6.13 Million USD | 0.0% |
| 2018 Q3 | -5.24 Million USD | 14.48% |
| 2018 FY | -23.67 Million USD | -0.56% |
| 2018 Q4 | -8.56 Million USD | -63.14% |
| 2017 FY | -23.54 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| America Great Health | -761.42 Thousand USD | -7659.449% |
| Ampio Pharmaceuticals, Inc. | -8.63 Million USD | -584.453% |
| Aridis Pharmaceuticals, Inc. | -30.74 Million USD | -92.143% |
| Biora Therapeutics, Inc. | -124.11 Million USD | 52.397% |
| Bio-Path Holdings, Inc. | -16.07 Million USD | -267.471% |
| Better Therapeutics, Inc. | -39.76 Million USD | -48.597% |
| Calithera Biosciences, Inc. | -18.86 Million USD | -213.167% |
| Comera Life Sciences Holdings, Inc. | -18.37 Million USD | -221.483% |
| Gene Biotherapeutics, Inc. | - USD | Infinity% |
| eFFECTOR Therapeutics, Inc. | -35.81 Million USD | -64.983% |
| Eloxx Pharmaceuticals, Inc. | -36.06 Million USD | -63.821% |
| Evelo Biosciences, Inc. | -114.52 Million USD | 48.412% |
| Evolutionary Genomics, Inc. | -2.24 Million USD | -2527.899% |
| Finch Therapeutics Group, Inc. | -74.75 Million USD | 20.965% |
| Innovation1 Biotech Inc. | -5.98 Million USD | -886.63% |
| Kiromic BioPharma, Inc. | -21.29 Million USD | -177.458% |
| Molecular Templates, Inc. | -8.12 Million USD | -627.253% |
| Navidea Biopharmaceuticals, Inc. | -15.17 Million USD | -289.282% |
| NexImmune, Inc. | -32.34 Million USD | -82.665% |
| Orgenesis Inc. | -55.36 Million USD | -6.721% |
| Panbela Therapeutics, Inc. | -25.26 Million USD | -133.868% |
| Point of Care Nano-Technology, Inc. | -78.01 Thousand USD | -75629.649% |
| PaxMedica, Inc. Common Stock | -18.28 Million USD | -223.034% |
| Scopus BioPharma Inc. | -11.6 Million USD | -408.896% |
| Sorrento Therapeutics, Inc. | -572.84 Million USD | 89.686% |
| Statera Biopharma, Inc. | -174.4 Million USD | 66.124% |
| TRACON Pharmaceuticals, Inc. | -3.58 Million USD | -1546.656% |
| Trevena, Inc. | -40.28 Million USD | -46.645% |
| Vaxxinity, Inc. | -56.93 Thousand USD | -103672.79% |
| Vaccinex, Inc. | -20.25 Million USD | -191.749% |
| Vicapsys Life Sciences, Inc. | -1.18 Million USD | -4898.004% |
| Viracta Therapeutics, Inc. | -51.05 Million USD | -15.715% |
| ZIVO Bioscience, Inc. | -7.77 Million USD | -659.684% |